Galapagos NV
GLPG
#5079
Rank
A$2.68 B
Marketcap
A$40.01
Share price
0.00%
Change (1 day)
-7.83%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.19 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are A$0.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$2.07 B-18.22%
2023-12-31A$2.53 B-27.2%
2022-12-31A$3.48 B-12.61%
2021-12-31A$3.98 B-18.29%
2020-12-31A$4.87 B-4.58%
2019-12-31A$5.10 B1296.68%
2018-12-31A$0.36 B-13.23%
2017-12-31A$0.42 B-11.01%
2016-12-31A$0.47 B307.18%
2015-12-31A$0.11 B21.69%
2014-12-31A$95.6 M-48.64%
2013-12-31A$0.18 B25.13%
2012-12-31A$0.14 B175.23%
2011-12-31A$54.05 M-9.18%
2010-12-31A$59.52 M7.14%
2009-12-31A$55.55 M-18.74%
2008-12-31A$68.36 M-18.29%
2007-12-31A$83.66 M-13.97%
2006-12-31A$97.25 M194.09%
2005-12-31A$33.07 M259.63%
2004-12-31A$9.19 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$172.71 B 86,768.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$83.28 B 41,791.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$206.42 B 103,725.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$91.64 B 45,995.08%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$119.39 B 59,952.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$96.13 B 48,252.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$86.83 B 43,575.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$0.16 B-15.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$45.89 B 22,982.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel